Concepedia

Amélie Tillmanns

AT

Statistics

Publications

4

Citations

160

H-Index

4

Active since

2015

Affiliations

University Hospital Münster(Current)

University Medical Center of the Johannes Gutenberg University Mainz

Institute of Social and Preventive Medicine

Copenhagen University Hospital

Erasmus MC

Amélie Tillmanns is an author at University Hospital Münster specializing in medicine, chemotherapy, and chemotherapy-induced ototoxicity.

Publications per year

2015–2021

4

Publications

4

Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study

Eva Clemens, Linda Broer, Thorsten Langer et al. · The Pharmacogenomics Journal · 2019 · 50 citations · Full text

Medicine, Otolaryngology, Pediatrics +17

Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease

Jenny Potratz, Amélie Tillmanns, Philipp Berning et al. · Molecular Oncology · 2015 · 45 citations · Full text

Medicine, Genetics, Oncology +13

Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study

Thorsten Langer, Eva Clemens, Linda Broer et al. · European Journal of Cancer · 2020 · 43 citations · Full text

Medicine, Genetics, Oncology +17

TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study

Annelot J. M. Meijer, Franciscus A. Diepstraten, Thorsten Langer et al. · npj Precision Oncology · 2021 · 22 citations · Full text

Medicine, Genetics, Oncology +17

1–4 of 4